NEXT
Sign in to follow

The Legal Intelligencer

Martin Shkreli’s Former Pharma Company Must Pay Attorney Fees Over Quashed Subpoena in Antitrust Row

U.S. District Judge J. Curtis Joyner of the Eastern District of Pennsylvania granted a motion to quash a subpoena issued by Retrophin, in which the company sought to depose an executive at Prinston Pharmaceuticals.
5 minute read

The American Lawyer

Judge Rules Exec Can Cite Alleged Weil Conflicts To Seek New Opioids Trial

The former national sales director for Insys claims that Weil's concurrent representation of him and his employer posed a conflict that requires a new trial.
3 minute read

Corporate Counsel

In-House Pharma Vet Joins Jazz Pharmaceuticals

Neena Patil, who held in-house roles at Novo Nordisk and Pfizer Inc., has become general counsel at Jazz Pharmaceuticals Inc.
3 minute read

Law.com

Judge Poised to Approve 'Negotiation' Class for Possible Opioid Settlement

At a hearing Tuesday, U.S. District Judge Dan Polster disagreed with many of those who objected to the proposal, including some of the defendants and state attorneys general.
7 minute read

The Legal Intelligencer

Supreme Court Won't Review $2.5M Risperdal Verdict

The Pennsylvania Supreme Court has declined to hear a Johnson & Johnson subsidiary's appeal in the first Risperdal lawsuit in Philadelphia to result in a plaintiff's verdict.
3 minute read

The Recorder

Judge Sets 'Very Low' Bar for Government's Dismissal of Gilead Qui Tam Case

U.S. District Judge Edward Chen said the level of scrutiny he would give to the government’s decision to ask to dismiss the case seeking hundreds of millions of dollars was “very low.”
5 minute read

The Recorder

Qui Tam Plaintiff Facing Dismissal Bid From Feds in Gilead Case

Lawyers with the DOJ's Civil Division and the U.S. Attorney's Office for the Northern District of California are asking a San Francisco judge to dismiss a long-running lawsuit bringing claims that hundreds of millions of dollars in government funds were spent on adulterated HIV drugs.
4 minute read

National Law Journal

Federal Circuit: No PTAB Immunity for Pre-AIA Patents

Inter partes review is enough like its predecessors not to represent an unconstitutional taking, Chief Judge Sharon Prost writes for the court.
4 minute read

Litigation Daily

Daily Dicta: Pfizer Spent a Fortune to Settle a Class Action. Will Its Insurers Share the Pain?

The fight over insurance coverage provides an interesting backdoor look at the Celebrex class action, which featured a long roster of top litigators.
4 minute read

Corporate Counsel

Experts to In-House Counsel at Drug Companies: Be Afraid, Be Very Afraid

General counsel and chief compliance officers at drugmakers are being scrutinized more by the U.S. Department of Justice as seen with recent indictments over the opioid crisis.
4 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • The Power of Online Reputation Management For Attorneys: A Critical Tool For Law Firms in 2025

    Brought to you by Erase.com

    Download Now

  • The Role of Evolving Support Structures in Optimizing Legal Talent

    Brought to you by BigHand

    Download Now

  • Corporate Monitorship Advisory Services

    Brought to you by HaystackID

    Download Now

  • AI-Powered Deposition and Medical Record Summaries: Low Risk, High Reward

    Brought to you by Parrot

    Download Now